Definitive Contract HHSN261201200060C
- Not listed
- This is a $199,828 Firm Fixed Price contract awarded by the National Cancer Institute (NCI), a component of the Department of Health and Human Services, to A&G Pharmaceutical, Inc. (doing business as Precision Antibody) for the development of "TECHNOLOGY GENERATED ANTI-PEPTIDE CAPTURE REAGENTS FOR AFFINITY ENRICHED PROTEOMIC STUDIES." The contract has a performance period ending on July 24, 2014 and was awarded on September 25, 2013. Precision Antibody is a for-profit...
- This contract award is for $16,490 to A&G Pharmaceutical, Inc. (doing business as A & G Pharmaceutical Inc. and Precision Antibody) by the National Institute of Allergy and Infectious Diseases (NIAID), an institute within the U.S. Department of Health and Human Services. The contract is a Blanket Purchase Agreement (BPA) call with a firm-fixed price pricing type. A&G Pharmaceutical is a for-profit manufacturer of goods specializing in custom antibody development services and...
- This is a firm fixed price purchase order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute on Aging to A&G Pharmaceutical, Inc. (doing business as Precision Antibody), a for-profit manufacturer of goods. The $14,630.25 contract is for the development of monoclonal antibodies to support biomedical research. Precision Antibody has provided similar services to HHS components like the National Cancer Institute and Department of...
- This is a $23,086.75 firm fixed price purchase order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute on Aging to A&G Pharmaceutical, Inc., doing business as Precision Antibody. Precision Antibody is a for-profit manufacturer of goods that provides custom antibody development services to support biomedical research. This contract is not set aside for small businesses. The award supports research efforts through the...
- This firm-fixed price purchase order was awarded to A&G Pharmaceutical, Inc. (doing business as Precision Antibody) by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services. The $7,951.40 award is for the delivery of custom antibody development services including monoclonal antibodies, cell lines, labeled antibodies, polyclonal antibodies, and peptide synthesis. These...
- This firm-fixed price purchase order was awarded by the Food and Drug Administration (FDA), a civilian agency within the U.S. Department of Health and Human Services (HHS), to A&G Pharmaceutical, Inc., doing business as Precision Antibody. The $9,750 contract is for the delivery of monoclonal antibodies. Precision Antibody is a for-profit manufacturer of goods that specializes in custom antibody development services to support biomedical research. The company has an extensive history of...
- The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences awarded a $132,862.50 firm fixed price delivery order contract to A&G Pharmaceutical, Inc., doing business as Precision Antibody, to support the agency's research efforts. Under the contract, TO6 - GENERATING MONOCLONAL CELL LINES, MONOCLONAL ANTIBODIES, AND LABELED MONOCLONAL ANTIBODIES AGAINST HUMAN AND MOUSE COLQ, Precision Antibody will provide monoclonal cell...
- The U.S. Department of Health and Human Services (HHS), through the National Institute of Allergy and Infectious Diseases (NIAID), awarded a $5,286.50 firm-fixed-price purchase order to A&G Pharmaceutical, Inc. (doing business as Precision Antibody) for custom antibody generation services. The award, with a completion date of December 18, 2013, is not associated with a set-aside designation. Precision Antibody is a for-profit manufacturer of goods specializing in custom antibody...
- This is a $5,820 firm-fixed price purchase order awarded by the National Institutes of Health (NIH) to A&G Pharmaceutical, Inc. (doing business as Precision Antibody) for monoclonal antibody production services. The contract is not set-aside and was awarded under the NIH's Acquisition Operations. Precision Antibody is a for-profit manufacturer of specialized biological materials and services, including custom antibody development, cell lines, and peptide synthesis, in support of biomedical...
- This is a firm-fixed price delivery order awarded by the National Center for Advancing Translational Sciences, a civilian agency within the U.S. Department of Health and Human Services, to A&G Pharmaceutical, Inc. (doing business as Precision Antibody), a for-profit manufacturer of goods. The $107,461.88 contract is for the delivery of polyclonal rat antibodies and monoclonal rat antibodies against glycol-chitosan nanoparticles. This award is part of a larger $100 million single-award...
This is a federal contract awarded by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services (HHS), to A&G Pharmaceutical, Inc. (doing business as Precision Antibody). The $199,380 firm-fixed-price contract is for research and development related to biomedical products and was awarded on September 14, 2012, with a completion date of September 13, 2013. The contract does not have a set-aside designation. A&G Pharmaceutical, Inc. is a for-profit manufacturer of goods that specializes in custom antibody development and related products to support biomedical research. The company has an extensive history of federal contract awards, primarily from NIH institutes, to provide specialized products and services. This includes a recent $100 million single-award Blanket Purchase Agreement (BPA) with the NIH Office of Logistics and Acquisition Operations, which allows various NIH components to place orders for the company's custom services in support of their biomedical research efforts.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| 2 | Other Administrative Action | $0 | 12/4/13 | |
| 1 | Other Administrative Action | $0 | 6/14/13 | |
| Not listed | Not listed | $199.4k | 9/14/12 |